Klaus Hoeffken

Results of a Prospective Randomised Open Label Phase III Study Comparing Rituximab Plus Mitoxantrone, Chlorambucile, Prednisolone Chemotherapy (R-MCP) Versus MCP Alone in Untreated Advanced Indolent Non-Hodgkin’s Lymphoma (NHL) and Mantle-Cell-Lymphoma (MCL).

Michael Herold, R. Pasold, Stefanie Srock et al. · Blood · 2004 · 72 citations

Medicine, Oncology, Pharmacotherapy +13

How many and which items of activities of daily living (ADL) and instrumental activities of daily living (IADL) are necessary for screening

Bernd Roehrig, Klaus Hoeffken, Ludger Pientka et al. · Critical Reviews in Oncology/Hematology · 2006 · 70 citations

Nursing, Health Sciences, Functional Assessment +13

Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia

W.-K. Hofmann, Gerhard Heil, C. Zander et al. · Annals of Hematology · 2004 · 57 citations

Medicine, Hematology, Oncology +17

Autologous intracoronary mononuclear bone marrow cell transplantation in chronic ischemic cardiomyopathy in humans

Friedhelm Kuethe, Barbara M. Richartz, Christoph Kasper et al. · International Journal of Cardiology · 2005 · 50 citations

Medicine, Cardiology, Internal Medicine +9

Remission with Imatinib mesylate treatment in a patient with initially unresectable dermatofibrosarcoma protuberans—a case report

Doreen Lemm, Lars-Olof Muegge, Klaus Hoeffken et al. · Oral and Maxillofacial Surgery · 2008 · 26 citations

Medicine, Dermatology, Oncology +9